Lingolol

UK<a href="https://www.europesays.com/uk/103097/" rel="nofollow noopener" translate="no" target="_blank">https://www.europesays.com/uk/103097/</a> Injecting medicine into amniotic fluid shows promise for treating genetic disorders <a href="https://pubeurope.com/tags/amniocentesis" class="mention hashtag" rel="nofollow noopener" target="_blank">#amniocentesis</a> <a href="https://pubeurope.com/tags/AmnioticFluid" class="mention hashtag" rel="nofollow noopener" target="_blank">#AmnioticFluid</a> <a href="https://pubeurope.com/tags/Antisense" class="mention hashtag" rel="nofollow noopener" target="_blank">#Antisense</a> <a href="https://pubeurope.com/tags/Biogen" class="mention hashtag" rel="nofollow noopener" target="_blank">#Biogen</a> <a href="https://pubeurope.com/tags/brain" class="mention hashtag" rel="nofollow noopener" target="_blank">#brain</a> <a href="https://pubeurope.com/tags/CentralNervousSystem" class="mention hashtag" rel="nofollow noopener" target="_blank">#CentralNervousSystem</a> <a href="https://pubeurope.com/tags/Children" class="mention hashtag" rel="nofollow noopener" target="_blank">#Children</a> <a href="https://pubeurope.com/tags/Genes" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genes</a> <a href="https://pubeurope.com/tags/Genetic" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetic</a> <a href="https://pubeurope.com/tags/Genetics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetics</a> <a href="https://pubeurope.com/tags/InUtero" class="mention hashtag" rel="nofollow noopener" target="_blank">#InUtero</a> <a href="https://pubeurope.com/tags/Medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#Medicine</a> <a href="https://pubeurope.com/tags/MuscularAtrophy" class="mention hashtag" rel="nofollow noopener" target="_blank">#MuscularAtrophy</a> <a href="https://pubeurope.com/tags/Nerve" class="mention hashtag" rel="nofollow noopener" target="_blank">#Nerve</a> <a href="https://pubeurope.com/tags/NervousSystem" class="mention hashtag" rel="nofollow noopener" target="_blank">#NervousSystem</a> <a href="https://pubeurope.com/tags/NeurodegenerativeDisease" class="mention hashtag" rel="nofollow noopener" target="_blank">#NeurodegenerativeDisease</a> <a href="https://pubeurope.com/tags/Oligonucleotides" class="mention hashtag" rel="nofollow noopener" target="_blank">#Oligonucleotides</a> <a href="https://pubeurope.com/tags/Research" class="mention hashtag" rel="nofollow noopener" target="_blank">#Research</a> <a href="https://pubeurope.com/tags/rna" class="mention hashtag" rel="nofollow noopener" target="_blank">#rna</a> <a href="https://pubeurope.com/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://pubeurope.com/tags/SpinalMuscularAtrophy" class="mention hashtag" rel="nofollow noopener" target="_blank">#SpinalMuscularAtrophy</a> <a href="https://pubeurope.com/tags/UK" class="mention hashtag" rel="nofollow noopener" target="_blank">#UK</a> <a href="https://pubeurope.com/tags/UnitedKingdom" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedKingdom</a>

UK<a href="https://www.europesays.com/uk/102414/" rel="nofollow noopener" translate="no" target="_blank">https://www.europesays.com/uk/102414/</a> Injecting medicine into amniotic fluid shows promise for treating genetic disorders <a href="https://pubeurope.com/tags/amniocentesis" class="mention hashtag" rel="nofollow noopener" target="_blank">#amniocentesis</a> <a href="https://pubeurope.com/tags/AmnioticFluid" class="mention hashtag" rel="nofollow noopener" target="_blank">#AmnioticFluid</a> <a href="https://pubeurope.com/tags/Antisense" class="mention hashtag" rel="nofollow noopener" target="_blank">#Antisense</a> <a href="https://pubeurope.com/tags/Biogen" class="mention hashtag" rel="nofollow noopener" target="_blank">#Biogen</a> <a href="https://pubeurope.com/tags/brain" class="mention hashtag" rel="nofollow noopener" target="_blank">#brain</a> <a href="https://pubeurope.com/tags/CentralNervousSystem" class="mention hashtag" rel="nofollow noopener" target="_blank">#CentralNervousSystem</a> <a href="https://pubeurope.com/tags/Children" class="mention hashtag" rel="nofollow noopener" target="_blank">#Children</a> <a href="https://pubeurope.com/tags/Genes" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genes</a> <a href="https://pubeurope.com/tags/Genetic" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetic</a> <a href="https://pubeurope.com/tags/Genetics" class="mention hashtag" rel="nofollow noopener" target="_blank">#Genetics</a> <a href="https://pubeurope.com/tags/InUtero" class="mention hashtag" rel="nofollow noopener" target="_blank">#InUtero</a> <a href="https://pubeurope.com/tags/Medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#Medicine</a> <a href="https://pubeurope.com/tags/MuscularAtrophy" class="mention hashtag" rel="nofollow noopener" target="_blank">#MuscularAtrophy</a> <a href="https://pubeurope.com/tags/Nerve" class="mention hashtag" rel="nofollow noopener" target="_blank">#Nerve</a> <a href="https://pubeurope.com/tags/NervousSystem" class="mention hashtag" rel="nofollow noopener" target="_blank">#NervousSystem</a> <a href="https://pubeurope.com/tags/NeurodegenerativeDisease" class="mention hashtag" rel="nofollow noopener" target="_blank">#NeurodegenerativeDisease</a> <a href="https://pubeurope.com/tags/Oligonucleotides" class="mention hashtag" rel="nofollow noopener" target="_blank">#Oligonucleotides</a> <a href="https://pubeurope.com/tags/Research" class="mention hashtag" rel="nofollow noopener" target="_blank">#Research</a> <a href="https://pubeurope.com/tags/rna" class="mention hashtag" rel="nofollow noopener" target="_blank">#rna</a> <a href="https://pubeurope.com/tags/Science" class="mention hashtag" rel="nofollow noopener" target="_blank">#Science</a> <a href="https://pubeurope.com/tags/SpinalMuscularAtrophy" class="mention hashtag" rel="nofollow noopener" target="_blank">#SpinalMuscularAtrophy</a> <a href="https://pubeurope.com/tags/UK" class="mention hashtag" rel="nofollow noopener" target="_blank">#UK</a> <a href="https://pubeurope.com/tags/UnitedKingdom" class="mention hashtag" rel="nofollow noopener" target="_blank">#UnitedKingdom</a>

The Japan TimesTwo new drugs, the first capable of slowing down the debilitating progression of Alzheimer's disease, have become embroiled in one of the biggest medical controversies in recent years. <a href="https://www.japantimes.co.jp/news/2024/09/21/world/science-health/alzheimers-drugs-controversy/" rel="nofollow noopener" translate="no" target="_blank">https://www.japantimes.co.jp/news/2024/09/21/world/science-health/alzheimers-drugs-controversy/</a> <a href="https://mastodon.social/tags/worldnews" class="mention hashtag" rel="nofollow noopener" target="_blank">#worldnews</a> <a href="https://mastodon.social/tags/sciencehealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#sciencehealth</a> <a href="https://mastodon.social/tags/dementia" class="mention hashtag" rel="nofollow noopener" target="_blank">#dementia</a> <a href="https://mastodon.social/tags/aging" class="mention hashtag" rel="nofollow noopener" target="_blank">#aging</a> <a href="https://mastodon.social/tags/alzheimer039s" class="mention hashtag" rel="nofollow noopener" target="_blank">#alzheimer039s</a> <a href="https://mastodon.social/tags/eisai" class="mention hashtag" rel="nofollow noopener" target="_blank">#eisai</a> <a href="https://mastodon.social/tags/biogen" class="mention hashtag" rel="nofollow noopener" target="_blank">#biogen</a> <a href="https://mastodon.social/tags/elililly" class="mention hashtag" rel="nofollow noopener" target="_blank">#elililly</a> <a href="https://mastodon.social/tags/drugs" class="mention hashtag" rel="nofollow noopener" target="_blank">#drugs</a> <a href="https://mastodon.social/tags/medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#medicine</a> <a href="https://mastodon.social/tags/brain" class="mention hashtag" rel="nofollow noopener" target="_blank">#brain</a>

The Japan TimesNine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's, Eisai and Biogen's Leqembi is facing an unexpected hurdle to widespread use. <a href="https://www.japantimes.co.jp/news/2024/04/24/world/science-health/alzheimer-drug-us-adoption-slow/" rel="nofollow noopener" translate="no" target="_blank">https://www.japantimes.co.jp/news/2024/04/24/world/science-health/alzheimer-drug-us-adoption-slow/</a> <a href="https://mastodon.social/tags/worldnews" class="mention hashtag" rel="nofollow noopener" target="_blank">#worldnews</a> <a href="https://mastodon.social/tags/sciencehealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#sciencehealth</a> <a href="https://mastodon.social/tags/alzheimers" class="mention hashtag" rel="nofollow noopener" target="_blank">#alzheimers</a> <a href="https://mastodon.social/tags/brain" class="mention hashtag" rel="nofollow noopener" target="_blank">#brain</a> <a href="https://mastodon.social/tags/eisai" class="mention hashtag" rel="nofollow noopener" target="_blank">#eisai</a> <a href="https://mastodon.social/tags/biogen" class="mention hashtag" rel="nofollow noopener" target="_blank">#biogen</a> <a href="https://mastodon.social/tags/leqembi" class="mention hashtag" rel="nofollow noopener" target="_blank">#leqembi</a> <a href="https://mastodon.social/tags/us" class="mention hashtag" rel="nofollow noopener" target="_blank">#us</a>

Carolyn Barber, MDdrug over the last two years hasn’t been reported. And, no refunds are being offered.We all remember the disastrous approval by the FDA of <a href="https://med-mastodon.com/tags/Biogen" class="mention hashtag" rel="nofollow noopener" target="_blank">#Biogen</a>'s Alzheimer's drug is <a href="https://med-mastodon.com/tags/Aduhelm" class="mention hashtag" rel="nofollow noopener" target="_blank">#Aduhelm</a>, which was “rife with irregularities” and involved “lapses in protocol." The good news here is that the drugmaker is pulling the drug off the market...<a href="https://med-mastodon.com/tags/medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#medicine</a> <a href="https://med-mastodon.com/tags/medtwitter" class="mention hashtag" rel="nofollow noopener" target="_blank">#medtwitter</a> <a href="https://med-mastodon.com/tags/pharma" class="mention hashtag" rel="nofollow noopener" target="_blank">#pharma</a> <a href="https://med-mastodon.com/tags/press" class="mention hashtag" rel="nofollow noopener" target="_blank">#press</a> By: Allsion DeAngelis <a href="https://www.statnews.com/2024/04/04/amylyx-to-pull-als-drug-relyvrio-from-market/" rel="nofollow noopener" translate="no" target="_blank">https://www.statnews.com/2024/04/04/amylyx-to-pull-als-drug-relyvrio-from-market/</a>

IT NewsBiogen dumps dubious Alzheimer’s drug after profit-killing FDA scandal - Enlarge / The exterior of the headquarters of biotechnology company Bio... - <a href="https://arstechnica.com/?p=2000435" rel="nofollow noopener" translate="no" target="_blank">https://arstechnica.com/?p=2000435</a> <a href="https://schleuss.online/tags/clinicaltrial" class="mention hashtag" rel="nofollow noopener" target="_blank">#clinicaltrial</a> <a href="https://schleuss.online/tags/aducanumab" class="mention hashtag" rel="nofollow noopener" target="_blank">#aducanumab</a> <a href="https://schleuss.online/tags/alzheimers" class="mention hashtag" rel="nofollow noopener" target="_blank">#alzheimers</a> <a href="https://schleuss.online/tags/science" class="mention hashtag" rel="nofollow noopener" target="_blank">#science</a> <a href="https://schleuss.online/tags/aduhelm" class="mention hashtag" rel="nofollow noopener" target="_blank">#aduhelm</a> <a href="https://schleuss.online/tags/health" class="mention hashtag" rel="nofollow noopener" target="_blank">#health</a> <a href="https://schleuss.online/tags/biogen" class="mention hashtag" rel="nofollow noopener" target="_blank">#biogen</a> <a href="https://schleuss.online/tags/fda" class="mention hashtag" rel="nofollow noopener" target="_blank">#fda</a>

The Japan TimesNew Alzheimer's drug lecanemab will cost around ¥2.98 million per year in Japan, but will be largely covered by public health insurance that will limit the burden for patients to between 10% and 30% of that cost, subject to a cap, a health ministry body has said. <a href="https://www.japantimes.co.jp/news/2023/12/13/japan/eisai-biogen-alzheimers-drug-price/?utm_content=buffer4dd52&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn" rel="nofollow noopener" translate="no" target="_blank">https://www.japantimes.co.jp/news/2023/12/13/japan/eisai-biogen-alzheimers-drug-price/?utm_content=buffer4dd52&utm_medium=social&utm_source=mastodon&utm_campaign=bffmstdn</a> <a href="https://mastodon.social/tags/japan" class="mention hashtag" rel="nofollow noopener" target="_blank">#japan</a> <a href="https://mastodon.social/tags/alzheimer039s" class="mention hashtag" rel="nofollow noopener" target="_blank">#alzheimer039s</a> <a href="https://mastodon.social/tags/drugs" class="mention hashtag" rel="nofollow noopener" target="_blank">#drugs</a> <a href="https://mastodon.social/tags/eisai" class="mention hashtag" rel="nofollow noopener" target="_blank">#eisai</a> <a href="https://mastodon.social/tags/biogen" class="mention hashtag" rel="nofollow noopener" target="_blank">#biogen</a> <a href="https://mastodon.social/tags/pharmaceuticals" class="mention hashtag" rel="nofollow noopener" target="_blank">#pharmaceuticals</a>

Brittany TrangSage's new <a href="https://newsie.social/tags/antidepressant" class="mention hashtag" rel="nofollow noopener" target="_blank">#antidepressant</a> is more like an antibiotic than an SSRI: it's taken for 14 days, then re-dosed as needed. But its long-term effectiveness is debatable.Turns out, it's so rapid-acting that some psychiatrists don't even care. But will the <a href="https://newsie.social/tags/FDA" class="mention hashtag" rel="nofollow noopener" target="_blank">#FDA</a>?My preview ahead of the FDA decision: www.statnews.com/2023/07/31/sage-zuranolone-antidepressant-fda/<a href="https://newsie.social/tags/depression" class="mention hashtag" rel="nofollow noopener" target="_blank">#depression</a> <a href="https://newsie.social/tags/sage" class="mention hashtag" rel="nofollow noopener" target="_blank">#sage</a> <a href="https://newsie.social/tags/biogen" class="mention hashtag" rel="nofollow noopener" target="_blank">#biogen</a> <a href="https://newsie.social/tags/ssri" class="mention hashtag" rel="nofollow noopener" target="_blank">#ssri</a> <a href="https://newsie.social/tags/health" class="mention hashtag" rel="nofollow noopener" target="_blank">#health</a> <a href="https://newsie.social/tags/mentalhealth" class="mention hashtag" rel="nofollow noopener" target="_blank">#mentalhealth</a> <a href="https://newsie.social/tags/healthcare" class="mention hashtag" rel="nofollow noopener" target="_blank">#healthcare</a> <a href="https://newsie.social/tags/medicine" class="mention hashtag" rel="nofollow noopener" target="_blank">#medicine</a> <a href="https://newsie.social/tags/biotech" class="mention hashtag" rel="nofollow noopener" target="_blank">#biotech</a> <a href="https://newsie.social/tags/pharma" class="mention hashtag" rel="nofollow noopener" target="_blank">#pharma</a>

Benjamin Carr, Ph.D. 👨🏻‍💻🧬Four senior <a href="https://hachyderm.io/tags/FDA" class="mention hashtag" rel="nofollow noopener" target="_blank">#FDA</a> leaders forged close ties with <a href="https://hachyderm.io/tags/Biogen" class="mention hashtag" rel="nofollow noopener" target="_blank">#Biogen</a> ahead of <a href="https://hachyderm.io/tags/Aduhelm" class="mention hashtag" rel="nofollow noopener" target="_blank">#Aduhelm</a>'s approval. Now they've all left FDA. Three of those four senior officials, who managed and worked closely with the clinical and biostats reviewers assigned to the Aduhelm application, have now ended up working at drugmakers <a href="https://endpts.com/four-senior-fda-leaders-forged-close-ties-with-biogen-ahead-of-aduhelms-approval-now-theyve-all-left-fda/" rel="nofollow noopener" target="_blank">https://endpts.com/four-senior-fda-leaders-forged-close-ties-with-biogen-ahead-of-aduhelms-approval-now-theyve-all-left-fda/</a> <a href="https://hachyderm.io/tags/revolvingdoor" class="mention hashtag" rel="nofollow noopener" target="_blank">#revolvingdoor</a> <a href="https://hachyderm.io/tags/quidproquo" class="mention hashtag" rel="nofollow noopener" target="_blank">#quidproquo</a>

Benjamin Carr, Ph.D. 👨🏻‍💻🧬Congressional inquiry into 'highly atypical' <a href="https://hachyderm.io/tags/FDA" class="mention hashtag" rel="nofollow noopener" target="_blank">#FDA</a>-<a href="https://hachyderm.io/tags/Biogen" class="mention hashtag" rel="nofollow noopener" target="_blank">#Biogen</a> ties ends with damning report, no repercussions, a slap on the wrist for both and a roadmap for how other companies may leverage behind-the-scenes interactions with FDA leaders to their advantage <a href="https://bit.ly/3Ckusy1" rel="nofollow noopener" target="_blank">https://bit.ly/3Ckusy1</a>

Recent searches

Search options

Administered by:

Server stats:

#biogen